$NSPX – Inspyr Therapeutics, Inc., promotional campaign starting Oct 12, 2020 @ 7:00 AM CST

on October 12, 2020 Stock Promotion Tracking and Tags: , , , , , , , , , with 0 comments


Start time:
7:00 AM
Start date:
October 12, 2020
Inspyr Therapeutics, Inc.
Stock promoter:
"Stock Sumo"
Stock promoter rank:
18 out of 29
Promoter score:
Campaign ID:

Inspyr Therapeutics, Inc.

Market capitalization:
(as of October 8, 2020)
Pink Current Information
Outsanding shares:
(as of August 6, 2020)

Stock Promoter Performance

The following charts displays the first day results for campaigns by "Stock Sumo". Results are taken from a total of 83 stock promotions by this stock promoter that have been tracked by OTC Dynamics.
53% closed down

37% closed up

9% had no net effect

Last 1 Stock Promotions By "Stock Sumo"

Symbol Company Start Date Close Change
LTUM Lithium Corporation. October 6, 2020 0.198 -40%

NSPX Promotional Newsletter

The following is a newsletter released by "Stock Sumo" promoting Inspyr Therapeutics, Inc.


The following newsletter has not been verified for accuracy or completeness.

We Outweigh the Competition

SPDR SP500 ETF SPY - Recap

On on quite a few fresh options ideas that were hitting our scanner, and with the help of a solid day for stocks in general, we saw a good amount of opportunity for success.

That also meant our running and new ideas for the SPY posted some nice figures on the day. We had been tracking SPY Weekly $340-341 Calls and we added the SPY Weekly $344-345 Calls to the radar as well.

Here were the final numbers on all of those, with some huge gains on the table

$340 .98-7.80 696%
$341 .75-6.24 732%
$344 1.48-3.41 130%
$345 .81-2.51 222%

More Options Recaps

As we mentioned above, we had quite a few options targets we were looking to ride into the close on Friday. That included targets in the CGC, X and BBBY chains, and each one of them was a good pick. Here are the potential gains that could've been made off of those plays

CGC Weekly $18 Calls
$18 .08-.37 363%

X Weekly $8 Calls
$8 .39-.73 87%

BBBY Weekly $21-22 Calls
$21 .43-.89 107%
$22 .03-.09 200%

Fresh Options Ideas
SPY Weekly $349-351 Calls
AAPL Weekly $118.75-121 Calls

Inspyr Therapeutics, Inc. NSPX - Chatroom Call

This is a good time to remind all of our readers that means YOU of your open invite into our daily live traders chats on Skype. We are always catching last minute plays that don't make it into our premarket reports.

Such was the case on Friday when we tagged NSPX before the open as you can see on the snapshot below. The stock turned around and posted a range of .0059-.0269 on the day, for a whopping 356% rip

- 1008

Get yourself onto Skype and send a contact request to username stocksumo and we'll get you observing andor participating in our live chats right away All are welcome

Extended Watchlist

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This is to be read and fully understood before using our site, or joining our email list. StockSumo.comSS does on occasion sell shares in the open market without notice,and on occasion is compensated by a Third-Party for its above-referenced services with the company stock .The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. SS and its affiliates are not registered or licensed investment advisers, nor broker dealers. SS advises that the investments in companies profiled are commonly considered to be high risk and use of the information provided is at the investor's sole risk.



Get Every Penny Stock Alert!

OTC Dynamics tracks all penny stock promotions. Become a member today and never miss another penny stock promotion!

Sign up today!


OTC Dynamics is not affiliated with the company being promoted or the associated stock promoter.

The information on this page is not a recommendation to buy or sell securities.